DarioHealth (DRIO) Net Cash Flow (2012 - 2026)

DarioHealth's Net Cash Flow history runs 15 years deep, the most recent figure standing at -$6.9 million for Q1 2026.

• Quarterly Net Cash Flow fell 6272.07% year-over-year to -$6.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$12.9 million (down 82.19% YoY) and the FY2025 annual result came in at -$6.0 million, up 33.41% from the prior year.
• Net Cash Flow was -$6.9 million for Q1 2026 at DarioHealth, up from -$10.1 million in the prior quarter.
• Across five years, Net Cash Flow topped out at $19.7 million in Q1 2022 and bottomed at -$11.4 million in Q2 2024.
• A 5-year average of -$1.2 million and a median of -$6.9 million in 2026 frame the typical range for Net Cash Flow.
• Annual changes were most pronounced in 2024 — Net Cash Flow soared 255.87% — and 2026, when it tumbled 6272.07%.
• DarioHealth's Net Cash Flow stood at -$7.7 million in 2022, then grew by 4.02% to -$7.4 million in 2023, then surged by 255.87% to $11.6 million in 2024, then plunged by 187.56% to -$10.1 million in 2025, then surged by 32.38% to -$6.9 million in 2026.
• Business Quant data shows DRIO's Net Cash Flow at -$6.9 million in Q1 2026, -$10.1 million in Q4 2025, and $10.0 million in Q3 2025.